Concepedia

G. Kenneth Lloyd

GK

Statistics

Publications

58

Citations

3.8K

H-Index

36

Active since

1977

Affiliations

Neurosciences Institute(Current)

Dana-Farber Cancer Institute

University of California San Diego

Multiple Myeloma Research Foundation

Kyoto Pharmaceutical University

G. Kenneth Lloyd is an author at Neurosciences Institute specializing in pharmacology, medicine, and neuroscience.

Publications per year

1977–2021

58

Publications

58

Neuronal Nicotinic Acetylcholine Receptors as Novel Drug Targets

G. Kenneth Lloyd, Michael Williams · Journal of Pharmacology and Experimental Therapeutics · 2000 · 312 citations

, , +17

Discovery and development of the anticancer agent salinosporamide A (NPI-0052)

William Fenical, Paul R. Jensen, Michael A. Palladino et al. · Bioorganic & Medicinal Chemistry · 2008 · 284 citations · Full text

, , +10

NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent

Benjamin Nicholson, G. Kenneth Lloyd, Brian Miller et al. · Anti-Cancer Drugs · 2005 · 253 citations

, , +14

Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization

Maryka Quik, Yelena Polonskaya, Alison Gillespie et al. · The Journal of Comparative Neurology · 2000 · 172 citations

, , +13

Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination

Michael Millward, Timothy Price, Amanda Townsend et al. · Investigational New Drugs · 2011 · 149 citations

, , +14

1–5 of 58